< 生产厂家价格 >

间溴溴苄

间溴溴苄用途

用于有机合成

点击显示

间溴溴苄名称

[ CAS 号 ]:
823-78-9

[ 中文名 ]:
3-溴苄溴

[ 英文名 ]:
3-Bromobenzyl bromide

[中文别名 ]:

[英文别名 ]:

a,o-dibromotoluene
|A,2-Dibromotoluene
Benzene, 1-bromo-3-(bromomethyl)-
3-Bromobenzyl bromide
m-bromobenzyl bromide
Benzene, 1-bromo-4-(bromomethyl)-
m-BrPhCH2Br
3-Brombenzyl bromide
ortho-bromo benzyl bromide
EINECS 212-519-1

间溴溴苄物理化学性质

[ 密度 ]:
1.9±0.1 g/cm3

[ 沸点 ]:
258.2±15.0 °C at 760 mmHg

[ 熔点 ]:
39-41 °C(lit.)

[ 分子式 ]:
C₇H₆Br₂

[ 分子量 ]:
249.930

[ 闪点 ]:
122.2±19.6 °C

[ 精确质量 ]:
247.883606

[ LogP ]:
3.69

[ 外观性状 ]:
白色晶体

[ 蒸汽压 ]:
0.0±0.5 mmHg at 25°C

[ 折射率 ]:
1.606

[ 储存条件 ]:
2-8°C

间溴溴苄MSDS

间溴溴苄安全信息

[ 符号 ]:

GHS05

[ 信号词 ]:
Danger

[ 危害声明 ]:
H314

[ 警示性声明 ]:
P280-P305 + P351 + P338-P310

[ 个人防护装备 ]:
Eyeshields;Faceshields;full-face particle respirator type N100 (US);Gloves;respirator cartridge type N100 (US);type P1 (EN143) respirator filter;type P3 (EN 143) respirator cartridges

[ 危害码 (欧洲) ]:
C:Corrosive;

[ 风险声明 (欧洲) ]:
R34

[ 安全声明 (欧洲) ]:
S26-S36/37/39-S45-S25

[ 危险品运输编码 ]:
UN 3261 8/PG 2

[ WGK德国 ]:
3

[ 包装等级 ]:
III

[ 危险类别 ]:
8

[ 海关编码 ]:
29036990

间溴溴苄合成路线

间溴溴苄上下游产品

间溴溴苄上游产品

间溴溴苄下游产品

间溴溴苄海关

[ 海关编码 ]: 2903999090

[ 中文概述 ]:
2903999090 其他芳烃卤化衍生物. 增值税率:17.0% 退税率:9.0% 监管条件:无最惠国关税:5.5% 普通关税:30.0%

[ 申报要素 ]: 品名, 成分含量, 用途

[ Summary ]:
2903999090 halogenated derivatives of aromatic hydrocarbons VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:5.5% General tariff:30.0%

间溴溴苄文献

Distributed Drug Discovery, Part 3: using D(3) methodology to synthesize analogs of an anti-melanoma compound.

J. Comb. Chem. 11(1) , 34-43, (2009)

For the successful implementation of Distributed Drug Discovery (D(3)) (outlined in the accompanying Perspective), students, in the course of their educational laboratories, must be able to reproducib...

Distributed Drug Discovery, Part 2: global rehearsal of alkylating agents for the synthesis of resin-bound unnatural amino acids and virtual D(3) catalog construction.

J. Comb. Chem. 11 , 14-33, (2009)

Distributed Drug Discovery (D(3)) proposes solving large drug discovery problems by breaking them into smaller units for processing at multiple sites. A key component of the synthetic and computationa...

Discovery of a substituted 8-arylquinoline series of PDE4 inhibitors: structure-activity relationship, optimization, and identification of a highly potent, well tolerated, PDE4 inhibitor.

Bioorg. Med. Chem. Lett. 15(23) , 5241-6, (2005)

The discovery and SAR of a new series of substituted 8-arylquinoline PDE4 inhibitors are herein described. This work has led to the identification of several compounds with excellent in vitro and in v...

更多文献